After charting multiple personalized medicine expansions in recent years, contract manufacturer Charles River Laboratories is back with another gene therapy pact—this time centered on an ...
Charles River Laboratories has entered a partnership deal with Rznomics, a South Korean biopharma, to develop and manufacture viral vectors for a gene therapy to treat liver cancer. The collaboration ...
On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for ...
Bristol Myers Squibb is breaking off its collaboration and license agreement with uniQure, calling time on a pact that was intended to deliver gene therapies against multiple cardiovascular disease ...
What can a therapist using a psychobiological approach to couples therapy help with? Psychobiological approach to couples therapy (PACT) was originally developed to treat couples in severe distress, ...
Charles River Laboratories International, Inc. CRL recently announced viral vector contract development and manufacturing organization (“CDMO”) partnership with Rznomics. Charles River’s viral vector ...
What can a therapist using a psychobiological approach to couples therapy help with? Psychobiological approach to couples therapy (PACT) was originally developed to treat couples in severe distress, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results